首页> 美国卫生研究院文献>Cell Cycle >Protect and serve: Bcl-2 proteins as guardians and rulers of cancer cell survival
【2h】

Protect and serve: Bcl-2 proteins as guardians and rulers of cancer cell survival

机译:保护和服务:Bcl-2蛋白可作为癌细胞存活的守护者和统治者

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It is widely accepted that anti-apoptotic Bcl-2 family members promote cancer cell survival by binding to their pro-apoptotic counterparts, thereby preventing mitochondrial outer membrane permeabilization (MOMP) and cytotoxic caspase activation. Yet, these proteins do not only function as guardians of mitochondrial permeability, preserving it, and maintaining cell survival in the face of acute or chronic stress, they also regulate non-apoptotic functions of caspases and biological processes beyond MOMP from diverse subcellular localizations and in complex with numerous binding partners outside of the Bcl-2 family. In particular, some of the non-canonical effects and functions of Bcl-2 homologs lead to an interplay with E2F-1, NFκB, and Myc transcriptional pathways, which themselves influence cancer cell growth and survival. We thus propose that, by feedback loops that we currently have only hints of, Bcl-2 proteins may act as rulers of survival signaling, predetermining the apoptotic threshold that they also directly scaffold. This underscores the robustness of the control exerted by Bcl-2 homologs over cancer cell survival, and implies that small molecules compounds currently used in the clinic to inhibit their mitochondrial activity may be not always be fully efficient to override this control.
机译:抗凋亡Bcl-2家族成员通过与促凋亡对应物结合而促进癌细胞存活,从而防止线粒体外膜通透性(MOMP)和细胞毒性半胱天冬酶活化,从而被广泛接受。然而,这些蛋白质不仅可以充当线粒体通透性的保护者,在面对急性或慢性应激时能保持其存活并维持细胞存活,还可以调节胱天蛋白酶的非凋亡功能和MOMP以外的多种亚细胞定位和分子生物学过程。 Bcl-2家族以外的众多具有约束力的伙伴的复合物。特别是,Bcl-2同源物的某些非规范作用和功能导致与E2F-1,NFκB和Myc转录途径的相互作用,而后者本身会影响癌细胞的生长和存活。因此,我们提出,通过我们目前仅提示的反馈环,Bcl-2蛋白可以充当生存信号的统治者,从而确定它们也直接支撑的凋亡阈值。这强调了Bcl-2同源物对癌细胞存活所施加的控制的鲁棒性,并暗示当前临床上用于抑制其线粒体活性的小分子化合物可能并不总是完全有效地克服该控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号